Get App Open
In App
Lending
Lending
Open App
you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01031 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 17, 16:01
1256.00 15.95 (1.29%)
Volume
AVERAGE VOLUME
5-Day
900,210
10-Day
509,591
30-Day
225,513
51,496
  • Prev. Close

    1240.05

  • Open Price

    1240.95

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 17, 15:57
1255.90 15.70 (1.27%)
Volume
AVERAGE VOLUME
5-Day
1,654,606
10-Day
1,847,336
30-Day
1,653,032
1,473,018
  • Prev. Close

    1240.20

  • Open Price

    1245.00

  • Bid Price (Qty.)

    1255.90 (102)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Profit & Loss account of Dr Reddys Laboratories (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 32,553.50 27,916.40 24,587.90 21,439.10 18,972.20  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 32,553.50 27,916.40 24,587.90 21,439.10 18,972.20  
Total Operating Revenues 32,643.90 28,011.10 24,669.70 21,545.20 19,047.50  
Other Income 1,097.30 894.30 1,055.50 484.40 291.40  
Total Revenue 33,741.20 28,905.40 25,725.20 22,029.60 19,338.90  
EXPENSES  
Cost Of Materials Consumed 5,683.50 4,490.10 4,219.80 4,312.40 4,295.80  
Purchase Of Stock-In Trade 4,841.10 4,399.10 3,367.00 3,483.70 2,573.60  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FGWIP And Stock In Trade -544.70 -680.50 70.90 -353.90 -790.50  
Employee Benefit Expenses 5,580.00 5,030.10 4,646.60 3,885.80 3,629.90  
Finance Costs 282.90 171.10 142.80 95.80 97.00  
Depreciation And Amortisation Expenses 1,703.70 1,470.00 1,250.20 1,165.20 1,228.80  
Other Expenses 8,367.60 6,838.90 5,946.50 5,519.10 4,792.00  
Total Expenses 26,083.40 21,719.10 19,713.70 19,038.50 16,503.40  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 7,657.80 7,186.30 6,011.50 2,991.10 2,835.50  
Exceptional Items 0.00 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 7,657.80 7,186.30 6,011.50 2,991.10 2,835.50  
Tax Expenses-Continued Operations  
Current Tax 2,258.10 1,945.90 814.40 1,101.30 817.20  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax -303.80 -322.80 726.80 -222.40 114.70  
Other Direct Taxes 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 1,954.30 1,623.10 1,541.20 878.90 931.90  
Profit/Loss After Tax And Before ExtraOrdinary Items 5,703.50 5,563.20 4,470.30 2,112.20 1,903.60  
Profit/Loss From Continuing Operations 5,703.50 5,563.20 4,470.30 2,112.20 1,903.60  
Profit/Loss For The Period 5,703.50 5,563.20 4,470.30 2,112.20 1,903.60  
Minority Interest -70.10 0.00 0.00 0.00 0.00  
Consolidated Profit/Loss After MI And Associates 5,655.10 5,577.90 4,507.30 2,182.50 1,951.60  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 68.00 335.00 271.00 132.00 118.00  
Diluted EPS (Rs.) 68.00 335.00 271.00 131.00 117.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 666.20 664.80 497.90 414.60 414.70  
Tax On Dividend 0.00 0.00 0.00 0.00 0.00  
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs